Literature DB >> 21278716

Diabetic nephropathy in 2010: Alleviating the burden of diabetic nephropathy.

Stephen P Gray1, Mark E Cooper.   

Abstract

Many patients with diabetic nephropathy progress to end-stage renal disease. New research in disease detection, diagnosis, and novel treatments will hopefully alleviate the burden of diabetic nephropathy in the future.

Entities:  

Mesh：

Year:  2011        PMID： 21278716     DOI： 10.1038/nrneph.2010.176

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


  9 in total

1.  Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial.

Authors:  Faramarz Ismail-Beigi; Timothy Craven; Mary Ann Banerji; Jan Basile; Jorge Calles; Robert M Cohen; Robert Cuddihy; William C Cushman; Saul Genuth; Richard H Grimm; Bruce P Hamilton; Byron Hoogwerf; Diane Karl; Lois Katz; Armand Krikorian; Patrick O'Connor; Rodica Pop-Busui; Ulrich Schubart; Debra Simmons; Harris Taylor; Abraham Thomas; Daniel Weiss; Irene Hramiak
Journal:  Lancet       Date:  2010-06-30       Impact factor: 79.321

2.  High-dose thiamine therapy for patients with type 2 diabetes and microalbuminuria: a randomised, double-blind placebo-controlled pilot study.

Authors:  N Rabbani; S S Alam; S Riaz; J R Larkin; M W Akhtar; T Shafi; P J Thornalley
Journal:  Diabetologia       Date:  2008-12-05       Impact factor: 10.122

3.  Plasma proteome analysis of patients with type 1 diabetes with diabetic nephropathy.

Authors:  Anne Julie Overgaard; Henning Gram Hansen; Maria Lajer; Lykke Pedersen; Lise Tarnow; Peter Rossing; James N McGuire; Flemming Pociot
Journal:  Proteome Sci       Date:  2010-02-03       Impact factor: 2.480

4.  A double-blind, randomized, placebo-controlled clinical trial on benfotiamine treatment in patients with diabetic nephropathy.

Authors:  Alaa Alkhalaf; Astrid Klooster; Willem van Oeveren; Ulrike Achenbach; Nanne Kleefstra; Robbert J Slingerland; G Sophie Mijnhout; Henk J G Bilo; Reinold O B Gans; Gerjan J Navis; Stephan J L Bakker
Journal:  Diabetes Care       Date:  2010-04-22       Impact factor: 17.152

5.  Nitric oxide synthesis is reduced in subjects with type 2 diabetes and nephropathy.

Authors:  Paolo Tessari; Diego Cecchet; Alessandra Cosma; Monica Vettore; Anna Coracina; Renato Millioni; Elisabetta Iori; Lucia Puricelli; Angelo Avogaro; Monica Vedovato
Journal:  Diabetes       Date:  2010-05-18       Impact factor: 9.461

6.  10-year follow-up of intensive glucose control in type 2 diabetes.

Authors:  Rury R Holman; Sanjoy K Paul; M Angelyn Bethel; David R Matthews; H Andrew W Neil
Journal:  N Engl J Med       Date:  2008-09-10       Impact factor: 91.245

7.  Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine.

Authors:  Roya Babaei-Jadidi; Nikolaos Karachalias; Naila Ahmed; Sinan Battah; Paul J Thornalley
Journal:  Diabetes       Date:  2003-08       Impact factor: 9.461

8.  Glucose control and vascular complications in veterans with type 2 diabetes.

Authors:  William Duckworth; Carlos Abraira; Thomas Moritz; Domenic Reda; Nicholas Emanuele; Peter D Reaven; Franklin J Zieve; Jennifer Marks; Stephen N Davis; Rodney Hayward; Stuart R Warren; Steven Goldman; Madeline McCarren; Mary Ellen Vitek; William G Henderson; Grant D Huang
Journal:  N Engl J Med       Date:  2008-12-17       Impact factor: 91.245

9.  Urine proteome analysis may allow noninvasive differential diagnosis of diabetic nephropathy.

Authors:  Massimo Papale; Salvatore Di Paolo; Riccardo Magistroni; Olga Lamacchia; Anna Maria Di Palma; Angela De Mattia; Maria Teresa Rocchetti; Luciana Furci; Sonia Pasquali; Salvatore De Cosmo; Mauro Cignarelli; Loreto Gesualdo
Journal:  Diabetes Care       Date:  2010-07-29       Impact factor: 17.152
  9 in total
  16 in total

Review 1.  Emerging roles for miRNAs in the development, diagnosis, and treatment of diabetic nephropathy.

Authors:  Johanna K DiStefano; Matthew Taila; M Lucrecia Alvarez
Journal:  Curr Diab Rep       Date:  2013-08       Impact factor: 4.810

2.  Angiotensin type 1 receptor mediates renal production and conversion of prostaglandins E2 to F2α in conscious diabetic rats.

Authors:  Peter M Abadir; Helmy M Siragy
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2015-07-20       Impact factor: 1.636

3.  Effects of preventative application of metformin on bile acid metabolism in high fat-fed/streptozotocin-diabetic rats.

Authors:  Lin Ding; Zhiping Qu; Jinfeng Chi; Rui Shi; Lulu Wang; Lulu Hou; Yan Wang; Shuguang Pang
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

4.  Towards microRNA-based therapeutics for diabetic nephropathy.

Authors:  M L Alvarez; J K DiStefano
Journal:  Diabetologia       Date:  2012-11-08       Impact factor: 10.122

5.  Low molecular weight fucoidan ameliorates diabetic nephropathy via inhibiting epithelial-mesenchymal transition and fibrotic processes.

Authors:  Jihui Chen; Wentong Cui; Quanbin Zhang; Yingli Jia; Yi Sun; Lin Weng; Dali Luo; Hong Zhou; Baoxue Yang
Journal:  Am J Transl Res       Date:  2015-09-15       Impact factor: 4.060

6.  Diabetic nephropathy amelioration by a low-dose sitagliptin in an animal model of type 2 diabetes (Zucker diabetic fatty rat).

Authors:  Cristina Mega; Edite Teixeira de Lemos; Helena Vala; Rosa Fernandes; Jorge Oliveira; Filipa Mascarenhas-Melo; Frederico Teixeira; Flávio Reis
Journal:  Exp Diabetes Res       Date:  2011-11-30

7.  A case control association study of COMT gene polymorphism (I/D) with type 2 diabetes and its related factors in Pakistani Punjabi population.

Authors:  Maryam Zain; Fazli Rabbi Awan; Sidra Amir; Shahid Mahmood Baig
Journal:  J Diabetes Metab Disord       Date:  2015-05-06

8.  Effects of stimulation of soluble guanylate cyclase on diabetic nephropathy in diabetic eNOS knockout mice on top of angiotensin II receptor blockade.

Authors:  Ina M Ott; Markus L Alter; Karoline von Websky; Axel Kretschmer; Oleg Tsuprykov; Yuliya Sharkovska; Katharina Krause-Relle; Jens Raila; Andrea Henze; Johannes-Peter Stasch; Berthold Hocher
Journal:  PLoS One       Date:  2012-08-10       Impact factor: 3.240

9.  Clinical value of NGAL, L-FABP and albuminuria in predicting GFR decline in type 2 diabetes mellitus patients.

Authors:  Kuei-Mei Chou; Chin-Chan Lee; Chih-Huang Chen; Chiao-Yin Sun
Journal:  PLoS One       Date:  2013-01-22       Impact factor: 3.240

10.  Endoplasmic reticulum stress-mediated hippocampal neuron apoptosis involved in diabetic cognitive impairment.

Authors:  Xiaoming Zhang; Linhao Xu; Daqiang He; Shucai Ling
Journal:  Biomed Res Int       Date:  2013-04-24       Impact factor: 3.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.